Karyopharm Therapeutics (NASDAQ: KPTI) has moved to session lows following Q2 results reported before markets opened Monday. Shares are ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Momentum Movers Trader Talk

Karyopharm (KPTI) Sell-Off Overdone, Leerink Partners SaysAugust 11, 2015 7:58 AM Form 10-Q Karyopharm Therapeutics For: Jun 30August 10, 2015 8:11 AM Karyopharm Therapeutics (KPTI) Misses Q2 EPS by 15cAugust 10, 2015 7:41 AM Form 8-K Karyopharm Therapeutics For: Aug 10August 10, 2015 7:37 AM